Selected EMA news, June 2025
New medicines recommended for approval
- Aucatzyl (obecabtagene autoleucel) – orphan medicine – conditional approval
Treatment of lymphoblastic leukaemia (blood cancer) - Blenrep (belantamab mafodotin)
Treatment of multiple myeloma (blood cancer)
Supply shortages
- NovoSeven (eptacog alfa) (eptacog alfa (activated))
Treatment of bleeding episodes and prevention of bleeding after surgical procedures